CHIMERA Pharma is a wholly owned subsidiary of BIONOSTRA Group founded in 2007 and focused on research and development of "Chimeric" Virus Like Particles (VLP) as vaccines for human health. The immune system plays a crucial role in the development of disease and CHIMERA strategy is focused in the development of immunotherapeutics against validated targets for infectious diseases, cancer and cardiovascular disease.
CHIMERA Pharma is a wholly owned subsidiary of BIONOSTRA Group founded in 2007 and focused on research and development of "Chimeric" Virus Like Particles (VLP) as vaccines for human health. The immune system plays a crucial role in the development of disease and CHIMERA strategy is focused in the development of immunotherapeutics against validated targets for infectious diseases, cancer and cardiovascular disease.